Biocatalytic Synthesis of Chiral Pharmaceutical Intermediates
The production of single enantiomers of drug intermediates has become increasingly important in the pharmaceutical industry. Chiral intermediates and fine chemicals are in high demand from both the pharmaceutical and agrochemical industries for the preparation of bulk drug substances and agricultura...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Zagreb
2004-01-01
|
Series: | Food Technology and Biotechnology |
Subjects: | |
Online Access: | http://hrcak.srce.hr/file/163397 |
id |
doaj-2b23eb6729d2464490e0c17b38daa030 |
---|---|
record_format |
Article |
spelling |
doaj-2b23eb6729d2464490e0c17b38daa0302020-11-25T02:57:33ZengUniversity of ZagrebFood Technology and Biotechnology1330-98621334-26062004-01-01424305325Biocatalytic Synthesis of Chiral Pharmaceutical IntermediatesRamesh N. Patel0Process R & D, Bristol-Myers Squibb, New Brunswick, NJ 08903, USAThe production of single enantiomers of drug intermediates has become increasingly important in the pharmaceutical industry. Chiral intermediates and fine chemicals are in high demand from both the pharmaceutical and agrochemical industries for the preparation of bulk drug substances and agricultural products. The enormous potential of microorganisms and enzymes for the transformation of synthetic chemicals with high chemo-, regio- and enantioselectivities has been demonstrated. In this article, biocatalytic processes are described for the synthesis of chiral pharmaceutical intermediates.http://hrcak.srce.hr/file/163397biocatalysischiral intermediatesanticancerantihypertensiveanti-infectiveenantioselective enzymatic de-protection |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ramesh N. Patel |
spellingShingle |
Ramesh N. Patel Biocatalytic Synthesis of Chiral Pharmaceutical Intermediates Food Technology and Biotechnology biocatalysis chiral intermediates anticancer antihypertensive anti-infective enantioselective enzymatic de-protection |
author_facet |
Ramesh N. Patel |
author_sort |
Ramesh N. Patel |
title |
Biocatalytic Synthesis of Chiral Pharmaceutical Intermediates |
title_short |
Biocatalytic Synthesis of Chiral Pharmaceutical Intermediates |
title_full |
Biocatalytic Synthesis of Chiral Pharmaceutical Intermediates |
title_fullStr |
Biocatalytic Synthesis of Chiral Pharmaceutical Intermediates |
title_full_unstemmed |
Biocatalytic Synthesis of Chiral Pharmaceutical Intermediates |
title_sort |
biocatalytic synthesis of chiral pharmaceutical intermediates |
publisher |
University of Zagreb |
series |
Food Technology and Biotechnology |
issn |
1330-9862 1334-2606 |
publishDate |
2004-01-01 |
description |
The production of single enantiomers of drug intermediates has become increasingly important in the pharmaceutical industry. Chiral intermediates and fine chemicals are in high demand from both the pharmaceutical and agrochemical industries for the preparation of bulk drug substances and agricultural products. The enormous potential of microorganisms and enzymes for the transformation of synthetic chemicals with high chemo-, regio- and enantioselectivities has been demonstrated. In this article, biocatalytic processes are described for the synthesis of chiral pharmaceutical intermediates. |
topic |
biocatalysis chiral intermediates anticancer antihypertensive anti-infective enantioselective enzymatic de-protection |
url |
http://hrcak.srce.hr/file/163397 |
work_keys_str_mv |
AT rameshnpatel biocatalyticsynthesisofchiralpharmaceuticalintermediates |
_version_ |
1724710582941122560 |